English 
Español 
français 
العربية Search
Search
Gliclazide is used to treat non-insulin-dependent diabetes mellitus. The mechanism of gliclazide is to selectively act on pancreatic islet β cells, promote insulin secretion, and increase insulin release after eating glucose, so that hepatic sugar production and output are inhibited. It has hypoglycemic effect on adult diabetics, and has the ability to reduce cholesterol accumulation, reduce the plasma concentration of aortic triphosphate glycerides and fatty acids, so gliclazide can not only treat diabetic metabolic disorders, but also prevent diabetic microangiopathy, improve retinopathy and kidney function.
| Items | Specifications | Results |
| Appearance | White or almost white powder | Conforms |
| Loss on drying | ≤0.25% | 0.04% |
| Sulfphated ash | ≤0.1% | 0.05% |
| Heavy metals | ≤10ppm | Conforms |
| Assay | 99.0%~101.0% | 99.41% |
| Product parameters | |
| Cas number: | 21187-98-4 |
| Appearance: | White or almost white powder |
| Purity: | 99~101% |
| Package details: | 1kg/foil bag; 25kg/fiber drum |
| Brand: | Fortunachem |
Hypoglycemic agents. It can be used for the treatment of non-insulin dependent diabetes mellitus.
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
